SVP and Chief Business Officer Michel Dahan sold $97K of Akebia Therapeutics, Inc.

Sold$96,500

$19.30Price

5,000Shares

−5%Stake

What AKBA did after the filing

Prices for AKBA after this filing aren't in yet.

Traded Thu, Sep 28. Filed Mon, Oct 2, 12:04 PM ET, during the session. Not investment advice.